Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT05523947 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

NCT05523947 · ClinicalTrials.gov record · last posted 2026-07-16

Clinical Trial of YH32367 in Patients With HER2 Positive Locally Advanced or Metastatic Solid Tumor

Name: Clinical Trial of YH32367 in Patients With HER2 Positive Locally Advanced or Metastatic Solid Tumor — clinical trial record (NCT05523947)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

StatusRecruiting

PhasePhase 1/2

SponsorYuhan Corporation

Started2022-08-26

View on ClinicalTrials.gov ↗

from the ClinicalTrials.gov record

This first-in-human study will be counducted to evaluate the safety, tolerability, pharmacokinetics (PK) and anti-tumor activity of YH32367 in Patients with HER2-Positive Locally Advanced or Metastatic Solid Tumors.

Amendment record 14 amendments on the ClinicalTrials.gov record

This ClinicalTrials.gov record has been amended 14 times since 2022-08-29; most recent amendment 2026-07-14. DataLookout shows field-level changes from the day a trial enters its daily monitoring; earlier amendments are counted here from the ClinicalTrials.gov version history. See every version on ClinicalTrials.gov ↗

2022-10-14

Status change Not Yet Recruiting→Recruitingv1

Trial Details

NCT Number	NCT05523947
Lead Sponsor	Yuhan Corporation
Conditions	HER2-Positive Solid Tumor
Enrollment	147 participants
Start Date	2022-08-26
Primary Completion	2028-03-31 (estimated)
Study Completion	2028-04-30 (estimated)
Updated on ClinicalTrials.gov	2026-07-16